API DESIGN LAYER — SYSTEM ARCHITECTURE
I. FRAMEWORK OVERVIEW
Component | Description |
Framework | SCF–PCR × Viragenesis × Multi-Omic Therapeutics |
Objective | Reverse viral-genomic instability and restore host coherence |
Target Domains | Genomic, Epigenetic, Bioenergetic, Immune |
Output | Multi-API therapeutic system (stackable or modular) |
Clinical Scope | Oncology, Autoimmune, Neurodegenerative, Fibrotic, Environmental Disease |
II. VIRAGENESIS CASCADE → API TARGET MAP
Cascade Stage | Primary Disruption | Molecular Targets | API Design Goal |
Stage 1: Genomic Instability | Viral integration / ERV activation | MLH1, MSH2, POLQ, ERV-LTRs | Restore repair fidelity, suppress integration |
Stage 2: Epigenetic Drift | DNA methylation / histone alteration | DNMT1, HDACs, HATs | Rebalance chromatin state |
Stage 3: Bioenergetic Collapse | NAD⁺ depletion, mitochondrial stress | SIRT1, PARP1, ETC complexes | Restore energy + redox balance |
Stage 4: Immune Desynchronization | Chronic inflammation, immune tolerance loss | PD-1/PD-L1, NF-κB, IL-6 | Normalize immune signaling |
III. API SYSTEM CLUSTER DESIGN
Cluster A — Anti-Viragenic Genome Stabilizers
Parameter | Specification |
API Code | VG-α1 |
Functional Class | DNA Repair Reactivator |
Primary Targets | MLH1, MSH2, MSH6 |
Mechanism of Action | Enhances mismatch repair fidelity, reduces replication errors |
Candidate Scaffolds | NAD⁺ boosters, PARP modulators, ATPase stabilizers |
SCF Role | Restore genomic coherence |
Delivery | Oral / IV / targeted nanoparticle |
Cluster B — Epigenetic Reset Modulators
Parameter | Specification |
API Code | VG-β2 |
Functional Class | Epigenetic Rebalancer |
Targets | DNMT1, HDAC, histone acetylation pathways |
Mechanism | Reverses CpG hypermethylation and |